Related Experiment Video
Updated: Sep 28, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB
R Ravi1, G C Bedi, L W Engstrom
1Johns Hopkins Oncology Center, The Johns Hopkins University School of Medicine, Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Baltimore, Maryland 21231, USA.
Abstract:
TRAIL (tumour-necrosis factor-related apoptosis ligand or Apo2L) triggers apoptosis through engagement of the death receptors TRAIL-R1 (also known as DR4) and TRAIL-R2 (DR5). Here we show that the c-Rel subunit of the transcription factor NF-kappaB induces expression of TRAIL-R1 and TRAIL-R2; conversely, a transdominant mutant of the inhibitory protein IkappaBalpha or a transactivation-deficient mutant of c-Rel reduces expression of either death receptor. Whereas NF-kappaB promotes death receptor expression, cytokine-mediated activation of the RelA subunit of NF-kappaB also increases expression of the apoptosis inhibitor, Bcl-xL, and protects cells from TRAIL. Inhibition of NF-kappaB by blocking activation of the IkappaB kinase complex reduces Bcl-x L expression and sensitizes tumour cells to TRAIL-induced apoptosis. The ability to induce death receptors or Bcl-xL may explain the dual roles of NF-kappaB as a mediator or inhibitor of cell death during immune and stress responses.
Insights
The transcription factor NF-kappaB, specifically its c-Rel subunit, regulates expression of death receptors TRAIL-R1 and TRAIL-R2. NF-kappaB also influences apoptosis by controlling Bcl-xL, impacting cell sensitivity to TRAIL-induced cell death.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Tumour-necrosis factor-related apoptosis ligand (TRAIL) induces apoptosis via death receptors TRAIL-R1 (DR4) and TRAIL-R2 (DR5).
- The transcription factor NF-kappaB plays a complex role in cellular responses, including apoptosis.
- Understanding NF-kappaB's regulation of TRAIL signaling is crucial for cancer therapy and immune responses.
Purpose of the Study:
- To investigate the role of the c-Rel subunit of NF-kappaB in regulating TRAIL death receptor expression.
- To determine how NF-kappaB activation influences the expression of the apoptosis inhibitor Bcl-xL.
- To elucidate the dual functions of NF-kappaB in mediating or inhibiting apoptosis.
Main Methods:
- Utilizing transdominant mutants of IkappaBalpha and transactivation-deficient c-Rel mutants to assess NF-kappaB's effect on death receptor expression.
- Employing cytokine-mediated activation to study the impact of RelA on Bcl-xL expression.
- Inhibiting NF-kappaB activation via the IkappaB kinase complex to evaluate its effect on Bcl-xL and TRAIL sensitivity.
Main Results:
- The c-Rel subunit of NF-kappaB was found to induce the expression of TRAIL-R1 and TRAIL-R2.
- Conversely, inhibition of NF-kappaB signaling led to reduced expression of these death receptors.
- Cytokine-mediated NF-kappaB activation (RelA) increased Bcl-xL expression, conferring resistance to TRAIL, while NF-kappaB inhibition sensitized cells to TRAIL.
Conclusions:
- NF-kappaB, through its subunits c-Rel and RelA, directly regulates the expression of TRAIL death receptors and the apoptosis inhibitor Bcl-xL.
- These regulatory functions explain the observed dual role of NF-kappaB as both a promoter and inhibitor of apoptosis.
- Targeting NF-kappaB signaling could modulate TRAIL-induced apoptosis in cancer treatment and immune regulation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

